Medically reviewed by Steffini Stalos, DOKey TakeawaysHepatitis B can be treated and prevented, but it cannot be ...

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage biotechnology company developing targeted oligonucleotide therapies for functional cure of chronic ...

The data demonstrated that finite-duration 24-week AHB-137 monotherapy achieved a 30% functional cure rate at Week 72 (EOF) in patients with baseline HBsAg 100--1,000 IU/mL. This finding strengthens ...

By focusing on chromatin-modifying enzymes, viral proteins, and noncoding RNAs, the researchers hope to uncover new pathways for a functional cure for chronic hepatitis B. The review highlights the ...

Please provide your email address to receive an email when new articles are posted on . As of 2019, the WHO estimates that nearly 300 million people worldwide are chronically infected with HBV, with ...

GlobalData forecasts the hepatitis B therapeutics market will more than double to $3.2B by 2034, driven by functional cure ...

A group of advisers to the Centers for Disease Control and Prevention is preparing to vote on whether the agency should scrap its long-standing recommendation that every baby get a hepatitis B vaccina ...

Spokane pediatrician Dr. Sarah d’Hulst has “basically never” treated a baby with hepatitis B. She fears that may change soon.

The acting CDC director adopted controversial guidance from the agency's advisory panel, upending a decadeslong policy. The ...

The U.S. Centers for Disease Control and Prevention (CDC) rescinded its long-standing advice on universal hepatitis B ...

Hepatitis B is not a particularly common condition in the United States. Data from 2021 estimates that between 880,000 and 1.89 million individuals are living with chronic hepatitis B in the U.S. This ...